Solid Tumor Clinical Trials

A listing of Solid Tumor medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 13 clinical trials
A Phase Ib Trial of Eribulin in Combination With Irinotecan and Temozolamide in Children With Relapsed or Refractory Solid Tumors

To find the recommended dose of eribulin that can be given in combination with irinotecan and temozolomide to treat relapsed and/or refractory solid tumors.

  • 0 views
  • 29 Aug, 2023
  • 1 location
Almonertinib Combined With Anlotinib as First-line Treatment for Advanced Non-small Cell Lung Cance

To evaluate the efficacy and safety of almonertinib plus anlotinib as first-line treatment for advanced non-small cell lung cancer with EGFR sensitive mutation and TP53 mutation. This study is an exploratory single-arm study. The specific treatment regimen is as follows: Non-squamous NSCLC: almonertinib (110 mg/d) plus anlotinib (12mg/d) is started …

  • 0 views
  • 22 Sep, 2023
  • 0 views
  • 04 Sep, 2023
  • 1 location
A Study of ADRX-0706 in Select Advanced Solid Tumors

The primary purpose of this study is to assess the safety, tolerability, and pharmacokinetics, and to identify the optimal dose of ADRX-0706 in patients with select advanced solid tumors.

  • 0 views
  • 18 Sep, 2023
  • 3 locations
Phase Ib Study of SY-3505 in Patients With Advanced LTK Fusion-Positive Solid Tumors

This is an open-label, single-arm, multicenter, phase Ib study to evaluate the efficacy and safety of SY-3505 capsule in patients with locally advanced or metastatic, LTK fusion-positive solid

  • 0 views
  • 18 Sep, 2023
  • 1 location
A Phase 1, Dose Escalation, Open-Label Study of Lntratumoral CAN1012 in Subjects With Unresectable or Metastatic Advanced Solid Tumors

To evaluate CAN1012 when administered by IT injection to subjects with advanced solid tumors who are not candidates for standard therapy.

  • 0 views
  • 20 Oct, 2022
  • 0 views
  • 22 Oct, 2022
  • 1 location
A Phase 1/2a Study Evaluating Allocetra-OTS as Monotherapy or in Combination With Anti-PD-1 Therapy for the Treatment of Advanced Solid Tumor Malignancy

This is an open-label, non-randomized, multicenter, Phase 1/2a study to evaluate the safety and potential efficacy of Allocetra-OTS in the treatment of advanced solid tumor malignancy as

  • 0 views
  • 25 Oct, 2022
  • 3 locations
Exploratory Study on Baize DC Injection in Preventing Recurrence and Metastasis After Radical Tumor Surgery

This is an exploratory study on the safety, immune response, and preliminary effectiveness of single arm, fixed dose therapy

  • 0 views
  • 06 Sep, 2023
Group Cognitive Behavior Sessions (CBCSM) to Decrease Distress in Cancer Patients

This clinical trial tests how well cognitive behavioral cancer stress management (CBCSM) group sessions work to decrease psychological distress in cancer patients. CBCSM teaches patients how to recognize and reduce the impacts of cancer associated stress on the biological, psychological, and social life domains.

  • 0 views
  • 02 Sep, 2023
  • 1 location